US$ 26.53
fda bpc-157 warning letter or statement Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Unregulated Peptide Use in the
Description
These compounds often work safely in combination with other drugs

Targeted therapy for intervertebral disc degeneration: inhibiting apoptosis is a promising treatment strategy, (in eng)
Avoid using the intravenous route
So we will need to tread carefully

It should be used within a specific timeframe as advised by your pharmacist, typically around 30 days
